Zosano Pharma, Inc. is private specialty pharmaceutical company creating products utilizing innovative drug delivery technology. Zosano Pharma was originally a group within ALZA Corporation, and has spun out through J & J Internal Ventures in October of 2006. The company has raised $75 million to progress several product opportunities based on the Macroflux transdermal technology through clinical development.